The APP/PS1 double-transgenic mice, carrying human APP (Swedish mutation) and PS1 (exon 9 deletion), are a widely used AD model that develops early amyloid plaque deposition, along with gliosis, synaptic dysfunction, and progressive cognitive deficits [260]. This evidence concerns the gene APP and amyloidosis.